| # | Objective | Tolerances | In Report |
| 1‐2 | QMP understands algorithms has received proper training | ||
| 2 | Develop schedule to acquire data, model and verify the dose algorithms | ||
| 3 | Consult manufacturer's guidance for data acquisition | ||
| 3.A | Verify operation, calibration of measurement equipment | ||
| 3.B | Acquire appropriate CT calibration data | ||
| 3.C | Review detector and corrections needs for small field measurements | ||
| 3.D | Review raw data (compare with published data, check for error, confirm import into TPS) | ||
| 4 | Model per manufacturer's instructions, compare to published data for same machine/TPS | ||
| 5.1 | Verify that TPS reproduces the absolute dose under reference calibration conditions | 0.5% | |
| 5.2 | Compare calculated dose in clinical planning module to calculated dose in physics module | Within statistical, grid size, and material definition uncertainty | |
| 5.3 | Perform spot checks comparing calculated dose in clinical planning module to commissioning data | 2% | |
| 5.4 | Small static (non‐SRS) MLC‐shaped fields |
2% in high dose region (one parameter change) 5% in high dose region (multiple parameters) 2 mm in penumbra 3% of max dose in low dose tail (up to 5 cm from field edge)
|
|
| 5.5 | MLC transmission, leaf overtravel, output factor effects | ||
| 5.6 | Off axis modelling including primary collimator | ||
| 5.7 | Field divergence and depth dose changes with SSD | ||
| 5.8 | Oblique surface incidence | ||
| 6.1 | Validate planning system reported electron (or mass) densities against known values | ||
| 6.2 | Heterogeneity correction distal to lung tissue | 3% | |
| 7.1 | Verify small field PDD |
2% of prescribed dose with ion chamber in low‐gradient region 3% of prescribed dose with ion chamber in high‐gradient region Evaluate planar/volumetric results at 2% local/2mm, pre‐treatment QA should pass >95% using 3% global/2mm and 10% threshold 5% of prescribed dose with end‐to‐end tests in low‐gradient region |
|
| 7.2 | Verify output for small MLC‐defined fields | ||
| 7.3 | TG‐119 tests | ||
| 7.4 | Clinical tests | ||
| 7.5 | External review | ||
| 8.1 | Verify the TPS reproduces the absolute dose under reference calibration conditions for electron energies | 0.5% | |
| 8.2 | Basic electron model verification with shaped fields | 3%/3 mm | |
| 8.3 | Electron surface irregularities/obliquity | 5% | |
| 8.4 | Electron inhomogeneity test | 7% | |
| 9 | Routine QA established, including baseline QA plan(s) identified for each configured beam |